Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality

被引:0
|
作者
Montserrat Vera-Llonch
Derek Weycker
Andrew Glass
Sue Gao
Rohit Borker
Angie Qin
Gerry Oster
机构
[1] Policy Analysis Inc (PAI),
[2] Kaiser Permanente Northwest,undefined
[3] Amgen Inc,undefined
来源
BMC Cancer | / 11卷
关键词
Cost; metastatic breast cancer; chemotherapy; burden of illness;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] ANTICIPATORY ANXIETY IN WOMEN RECEIVING CHEMOTHERAPY FOR BREAST-CANCER
    JACOBSEN, PB
    BOVBJERG, DH
    REDD, WH
    HEALTH PSYCHOLOGY, 1993, 12 (06) : 469 - 475
  • [32] Weight gain in women receiving adjuvant chemotherapy for breast cancer
    FaberLangendoen, K
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (11): : 855 - 856
  • [33] Real-World Analysis of Medical Costs and Healthcare Resource Utilization in Elderly Women with HR+/HER2− Metastatic Breast Cancer Receiving Everolimus-Based Therapy or Chemotherapy
    Yanni Hao
    Nanxin Li
    Anna P. Fang
    Valerie Koo
    Miranda Peeples
    Andrew Kageleiry
    Eric Q. Wu
    Annie Guérin
    Advances in Therapy, 2016, 33 : 983 - 997
  • [34] Real-World Analysis of Medical Costs and Healthcare Resource Utilization in Elderly Women with HR+/HER2-Metastatic Breast Cancer Receiving Everolimus-Based Therapy or Chemotherapy
    Hao, Yanni
    Li, Nanxin
    Fang, Anna P.
    Koo, Valerie
    Peeples, Miranda
    Kageleiry, Andrew
    Wu, Eric Q.
    Guerin, Annie
    ADVANCES IN THERAPY, 2016, 33 (06) : 983 - 997
  • [35] REAL-WORLD ANALYSIS OF MEDICAL COSTS AND HEALTHCARE RESOURCE UTILIZATION IN ELDERLY WOMEN WITH HR+/HER2-METASTATIC BREAST CANCER RECEIVING EVEROLIMUS-BASED THERAPY OR CHEMOTHERAPY
    Hao, Y.
    Li, N.
    Fang, A.
    Koo, V
    Peeples, M.
    Kageleiry, A.
    VALUE IN HEALTH, 2016, 19 (03) : A145 - A145
  • [36] Use and Costs of Disease Monitoring in Women With Metastatic Breast Cancer
    Accordino, Melissa K.
    Wright, Jason D.
    Vasan, Sowmya
    Neugut, Alfred I.
    Hillyer, Grace C.
    Hu, Jim C.
    Hershman, Dawn L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (24) : 2820 - +
  • [37] How women receiving adjuvant chemotherapy for breast cancer cope with their treatment: a risk management perspective
    Cowley, L
    Heyman, B
    Stanton, M
    Milner, SJ
    JOURNAL OF ADVANCED NURSING, 2000, 31 (02) : 314 - 321
  • [38] TREATMENT OF METASTATIC BREAST CANCER WITH 5 DRUG CHEMOTHERAPY
    CERVEK, J
    SUMIKRIZ.T
    ZDRAVSTVENI VESTNIK, 1974, 43 (10): : 545 - 546
  • [39] Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer
    Fornier, M
    Esteva, FJ
    Seidman, AD
    SEMINARS IN ONCOLOGY, 2000, 27 (06) : 38 - 45
  • [40] Metronomic Chemotherapy as a Treatment Option for metastatic Breast Cancer
    Krajnak, S.
    Anic, K.
    Almstedt, K.
    Heimes, A-S
    Krajnakova, J.
    Linz, V
    Loewe, A.
    Hasenburg, A.
    Schmidt, M.
    Battista, M. J.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (10) : E109 - E109